Longitudinal study of influenza molecular viral shedding in Hutterite communities.
暂无分享,去创建一个
Pardeep Singh | Kanti Pabbaraju | Sallene Wong | Richard Webby | Binod Neupane | Mark Loeb | K. Pabbaraju | R. Webby | M. Loeb | M. Russell | K. Fonseca | J. Fox | B. Neupane | Paramjit Singh | Pardeep Singh | Margaret L Russell | Kevin Fonseca | Paramjit K Singh | Julie Fox | Danielle Zarra | Danielle Zarra | S. Wong
[1] L. Nashef,et al. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. , 1985, Journal of clinical pathology.
[2] R. Karron,et al. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers , 1992, Journal of clinical microbiology.
[3] C. Hall,et al. Children with influenza A infection: treatment with rimantadine. , 1987, Pediatrics.
[4] L. Finelli,et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.
[5] B. Murphy,et al. ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTION , 1984, The Lancet.
[6] T. Mazzulli,et al. Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses , 2011, PloS one.
[7] Simon Cauchemez,et al. Transmission Characteristics of the 2009 H1N1 Influenza Pandemic: Comparison of 8 Southern Hemisphere Countries , 2011, PLoS pathogens.
[8] R. Douglas,et al. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. , 1971, The Journal of infectious diseases.
[9] R. Betts,et al. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. , 1998, Vaccine.
[10] Benjamin J Cowling,et al. Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections , 2010, The Journal of infectious diseases.
[11] F. Hayden,et al. Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans , 1994, Antimicrobial Agents and Chemotherapy.
[12] F. Hayden,et al. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. , 1997, The Journal of infectious diseases.
[13] F. Hayden,et al. Respiratory nitric oxide levels in experimental human influenza. , 1998, Chest.
[14] G. Schiff,et al. Complement is activated in the upper respiratory tract during influenza virus infection. , 1991, The American review of respiratory disease.
[15] B. Murphy,et al. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. , 1990, The Journal of infectious diseases.
[16] A. Leibovitz,et al. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. , 1971, The Journal of infectious diseases.
[17] S. Carruthers,et al. Development and Evaluation of a Flocked Nasal Midturbinate Swab for Self-Collection in Respiratory Virus Infection Diagnostic Testing , 2010, Journal of Clinical Microbiology.
[18] M. Epstein,et al. DEATHS IN THE COMMUNITY. , 1964, Lancet.
[19] F. Hayden,et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.
[20] J. W. Little,et al. Attenuated influenza produced by experimental intranasal inoculation , 1979, Journal of medical virology.
[21] B. Murphy,et al. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. , 1988, The Journal of infectious diseases.
[22] P. Daley,et al. Comparison of Flocked and Rayon Swabs for Collection of Respiratory Epithelial Cells from Uninfected Volunteers and Symptomatic Patients , 2006, Journal of Clinical Microbiology.
[23] F. Hayden,et al. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. , 1996, JAMA.
[24] F. Hayden,et al. Increased Interleukin-6 Levels in Nasal Lavage Samples following Experimental Influenza A Virus Infection , 1998, Clinical Diagnostic Laboratory Immunology.
[25] A. Frank,et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. , 1981, The Journal of infectious diseases.
[26] N. Ferguson,et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.
[27] J. Langley,et al. Prevention of influenza in the general population , 2004, Canadian Medical Association Journal.
[28] W. Doyle,et al. Illness and Otological Changes During Upper Respiratory Virus Infection , 1999, The Laryngoscope.
[29] F. Hayden,et al. Nasal and Otologic Effects of Experimental Influenza a Virus Infection , 1994, The Annals of otology, rhinology, and laryngology.
[30] P. Wright,et al. Differing virulence of H1N1 and H3N2 influenza strains. , 1980, American journal of epidemiology.
[31] F. Hayden,et al. Influenza A virus--induced acute otitis media. , 1995, The Journal of infectious diseases.
[32] W. M. Shepherd,et al. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers. , 1984, Journal of interferon research.
[33] R. Betts,et al. Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans , 1994, Journal of clinical microbiology.
[34] Pan Xin,et al. Novel Swine-Origin Influenza A(H1N1) Virus , 2009 .
[35] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[36] B. Murphy,et al. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine , 1986, Journal of clinical microbiology.
[37] R. Couch,et al. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. , 1991, American journal of epidemiology.